A cross-sectional study revealed that increasing vitamin A intake may improve depressive symptoms in patients with heart failure.
According to Chinese researchers, daily intake of vitamin A above 731.38 µg was significantly associated with a lower odds of depressive symptoms.

“Vitamin A acts as an antioxidant, protecting against oxidative damage and reducing inflammation by inhibiting the production of inflammatory cytokines,” the researchers wrote. “By moderating these processes, vitamin A may help reduce the incidence of depression.” [patients with heart failure].”
That was the headline news in cardiology last week.
In other headline news, researchers found that weight loss surgery leads to improved clinical outcomes in patients with heart failure and obesity: After 24 months, patients’ BMI and HbA1c decreased, as did their reliance on diuretics.
Read these and other top stories in cardiology below:
Vitamin A intake may improve depression in patients with heart failure
Increasing vitamin A intake can help reduce depression in patients with heart failure, according to a cross-sectional study published in the Journal of the American Heart Association. ESC: Heart failure. read more.
Weight loss surgery appears to benefit patients with heart failure and obesity
Researchers report that in a single-center cohort of patients with heart failure and obesity, weight loss surgery was associated with improved clinical outcomes, including lower BMI and HbA1c, and reduced dependency on diuretics. Read more.
Q&A: New Efforts to Address CKM Syndrome Affecting Millions in the U.S.
In October 2023, the American Heart Association introduced the term cardiovascular-renal-metabolic syndrome to reflect the link between metabolic and renal conditions related to the risk of heart disease. Read more.
Addressing Medication Nonadherence to Improve Heart Failure Management and Outcomes
Medication adherence, or the extent to which an individual’s behavior aligns with a provider’s recommendations, is an unsolved challenge in healthcare. Four pharmacology experts discuss how a “shared approach” using multiple strategies can improve medication adherence and outcomes for heart failure patients. Read more.
Treating obesity can prevent and slow the progression of hypertension
The disease of obesity often has cardiometabolic effects, including hypertension, which remains the strongest predictive risk factor for cardiovascular disease. Read more.